Literature DB >> 6188885

Quinine and quinidine: a comparison of EKG effects during the treatment of malaria.

N J White, S Looareesuwan, D A Warrell.   

Abstract

We recorded electrocardiograms from 31 patients receiving quinine and 14 patients receiving quinidine for the treatment of Plasmodium falciparum malaria. Despite plasma quinine concentrations of up to 20 mg/L, there was no evidence of cardiotoxicity. QT prolongation was considerably greater in the quinidine-treated patients. The mean ratio of change in corrected QT interval to change in plasma concentration (delta QTc%/delta CQ) was 3.2% . mg-1 . L-1 for quinidine, compared to 0.74% . mg-1 . L-1 for quinine (p less than 0.001). T-wave flattening was observed in both groups. Plasma concentrations of quinine cannot be predicted from the EKG, because concentrations within the therapeutic range produced only minor and unpredictable abnormalities.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6188885     DOI: 10.1097/00005344-198303000-00001

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  27 in total

1.  Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation.

Authors:  Y G Yap; J Camm
Journal:  BMJ       Date:  2000-04-29

Review 2.  Pharmacology and parasitology: integrating experimental methods and approaches to falciparum malaria.

Authors:  P A Winstanley; W M Watkins
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

Review 3.  Cardiac complications of unwitting co-injection of quinine/quinidine with heroin in an intravenous drug user.

Authors:  Karran A Phillips; Glenn A Hirsch; David H Epstein; Kenzie L Preston
Journal:  J Gen Intern Med       Date:  2012-05-17       Impact factor: 5.128

4.  The treatment of severe falciparum malaria.

Authors:  W Peters; A P Hall
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-26

Review 5.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

6.  Severe Malaria Complicated by G6PD Deficiency in a Pediatric Tanzanian Immigrant.

Authors:  Heather N Damhoff; Robert J Kuhn; Laura P Stadler
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

7.  Divided dose intramuscular regimen and single dose subcutaneous regimen for chloroquine: plasma concentrations and toxicity in patients with malaria.

Authors:  R E Phillips; D A Warrell; G Edwards; Y Galagedera; R D Theakston; D T Abeysekera; P Dissanayaka
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-05

8.  Effects of anti-malarial drugs on the electrocardiographic QT interval modelled in the isolated perfused guinea pig heart system.

Authors:  Atsushi Kinoshita; Harumi Yamada; Hajime Kotaki; Mikio Kimura
Journal:  Malar J       Date:  2010-11-10       Impact factor: 2.979

9.  Cardiovascular toxicity and distribution kinetics of intravenous chloroquine.

Authors:  S Looareesuwan; N J White; P Chanthavanich; G Edwards; D D Nicholl; C Bunch; D A Warrell
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

Review 10.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.